| Baseline ARR | ₹0.06 CrYear-1 Projection |
|---|---|
| Market Cap | ₹217.34 CrSmall Cap |
| Net Profit TTM | ₹19.55 CrLTM Earnings |
| Day RSI | 72.25Overbought Zone |
| Execution period | Year-1 |
| Deal value | ₹0.06 Cr |
| Share of market cap | 0.0% |
Key highlights
- Registered a highly engaged waitlist of over 5,620 users during the soft launch phase
- Annual subscription pricing set at ₹999 to drive deep penetration in the domestic retail market
- Projected initial conversion of 600 to 900 active paying subscribers in the first year
- Phase 1 growth milestone targets 10,000 paying subscribers to reach a ₹1 Crore ARR run-rate
- Long-term Phase 2 roadmap aims for 1.20 lakh subscribers and up to ₹12 Crore ARR
The Product — What It Is
Ashwini Healthcare AI is a cloud-native HealthTech platform accessible via the official portal at www.ashwini.tech. Engineered on a scalable Software-as-a-Service architecture, the platform provides AI-driven personal health insights by mirroring the unit economics and retention metrics found in premium global wearable and performance ecosystems. The interface is designed to integrate data from various health monitors to deliver actionable wellness intelligence to retail users.
This digital solution focuses on user stickiness through high-frequency engagement, targeting individuals looking for data-backed health management tools in the Indian market.
Commercial Opportunity
- Conversion metrics for the initial cohort are modeled between 8% and 15% of the current waitlist
- Subscription model ensures high gross margins by leveraging low-cost digital distribution
- Phase 1 operational targets focus on achieving a ₹1 Crore ARR through 10,000 active users
- Phase 2 institutional-grade scaling targets up to 1,20,000 subscribers to unlock Series-A valuation metrics
- Internal operational targets aim for a 65% to 70% annual user retention rate
Strategic Pivot and Financial Context
This launch represents a significant strategic pivot for AVI Polymers from its traditional specialty chemicals background into high-visibility digital platforms. The move is designed to establish recurring revenue streams that are not tied to the cyclicality of chemical raw materials. Despite a recent decline in promoter holding to 1.1%, the company has demonstrated strong financial momentum with a net profit growth of 1278% YoY in the latest quarter.
The management intends to scale this SaaS roadmap to deliver compounded, debt-free growth by utilizing existing cash flows to fund digital expansion.
Industry Context
The Indian HealthTech and Wellness SaaS market is undergoing rapid expansion as consumers increasingly adopt digital-first preventive healthcare tools. AVI Polymers is entering a sector characterized by high entry barriers for effective AI modeling but significant rewards for platforms that can maintain high retention rates. By benchmarking its performance against global wearable ecosystems, the company aims to capitalize on the increasing penetration of affordable smartphones and high-speed data across domestic retail segments, where low-cost annual subscriptions are becoming the standard for premium wellness services.
“We remain exceptionally confident in our ability to scale this SaaS roadmap and deliver compounded, debt-free growth to our shareholders.”
| Share price | ₹23.1 |
|---|---|
| Market capitalisation | ₹217.34 Cr |
| Revenue (annual) | ₹312.11 Cr |
| Net profit (annual) | ₹20.33 Cr |
| Revenue (latest quarter) | ₹150.28 Cr+13.58% vs previous quarter |
| Net profit (latest quarter) | ₹10.24 Cr+45.92% vs previous quarter |
| P/E (TTM) | 11.11×Sector 41.91× |
| Promoter holding | 1.1%-24.09% QoQ |
| FII holding | 0%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by AVI Polymers Ltd announcing the soft launch and early adoption metrics for Ashwini Healthcare AI. Market figures from a third-party data provider.
